Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice
- PMID: 3950582
- DOI: 10.1099/0022-1317-67-3-591
Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice
Abstract
The capacity of monoclonal antibodies to protect mice passively against yellow fever (YF) virus infection was investigated. Both neutralizing (54K-specific) and non-neutralizing (54K- and 48K-specific) antibodies protected mice against challenge with the RMP substrain of YF virus. Average survival times of mice inoculated intracerebrally with a standard lethal dose of YF virus differed according to the strain used: thus mice inoculated with the most neurovirulent viruses, FNV and Asibi, survived for 6 X 50 and 7 X 65 days respectively, and those with RMP virus survived for 15 X 75 days. The capacity of antibodies to protect mice passively against virus challenge was directly related to virus neurovirulence. Possible mechanisms and the significance of protection by antibodies against non-structural proteins that do not mediate neutralization, are discussed.
Similar articles
-
Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.J Gen Virol. 1995 Jan;76 ( Pt 1):217-20. doi: 10.1099/0022-1317-76-1-217. J Gen Virol. 1995. PMID: 7844536
-
Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.J Gen Virol. 1986 Feb;67 ( Pt 2):229-34. doi: 10.1099/0022-1317-67-2-229. J Gen Virol. 1986. PMID: 3944585
-
Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.J Gen Virol. 1985 Jul;66 ( Pt 7):1369-82. doi: 10.1099/0022-1317-66-7-1369. J Gen Virol. 1985. PMID: 2410549
-
Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.J Gen Virol. 1985 Dec;66 ( Pt 12):2523-31. doi: 10.1099/0022-1317-66-12-2523. J Gen Virol. 1985. PMID: 2999305
-
Antibody-mediated early death in vivo after infection with yellow fever virus.J Gen Virol. 1986 Nov;67 ( Pt 11):2539-42. doi: 10.1099/0022-1317-67-11-2539. J Gen Virol. 1986. PMID: 3783130
Cited by
-
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.J Virol. 2007 Dec;81(23):12816-26. doi: 10.1128/JVI.00432-07. Epub 2007 Sep 19. J Virol. 2007. PMID: 17881453 Free PMC article.
-
Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model.J Virol. 1997 Apr;71(4):2921-7. doi: 10.1128/JVI.71.4.2921-2927.1997. J Virol. 1997. PMID: 9060650 Free PMC article.
-
Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virus. Brief report.Arch Virol. 1987;93(3-4):295-301. doi: 10.1007/BF01310983. Arch Virol. 1987. PMID: 3827600
-
Flavivirus nonstructural protein NS1: complementary surprises.Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):18879-80. doi: 10.1073/pnas.0609522103. Epub 2006 Dec 4. Proc Natl Acad Sci U S A. 2006. PMID: 17146046 Free PMC article. No abstract available.
-
A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.mBio. 2020 Apr 7;11(2):e02494-19. doi: 10.1128/mBio.02494-19. mBio. 2020. PMID: 32265332 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
